USPTO 2015–2025 USPTO PatentsView US Corporation

ARK Therapeutic Services, Inc.

USPTO PatentsView assignee record - 40 granted patents across 0 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, ARK ranks #7,977 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 0 technology areas.

#7,977
of 49,997 US assignees by volume
10th percentile
by Innovation Score (22.4/100)
1.0
avg claims per patent
+800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7977 · US Corporation #7,977 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-UNK · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-RICH

  • GRANTS-SMALL 40 grants
  • UPPER-Q #7,977/49,997
  • PHOTO-FINISH ActiveVideo Networks
  • CPC-UNK CPC blank
  • INNOV-THIN 22.4/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +800% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: ActiveVideo Networks, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ARK’s 22.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around ARK

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows ARK's Innovation Score is 22.4/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for ARK?

Each dot is one of ARK’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ARK’s own 1.0 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

ARK vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 39.940.040.04040.040.040.1 010203040 Granted patents (volume) Avg claims / patent Alios Biopharma, Inc. - 40, 29.5Alios BiopharmaAmcor Rigid Packaging USA, LLC - 40, 15.4Amcor Rigid Packa…Anchor Hocking, LLC - 40, 2.95Anchor HockingAR & NS Investment, LLC - 40, 19.48AR & NS InvestmentAutomated Assembly Corporation - 40, 21.4Automated AssemblyAzurity Pharmaceuticals, Inc. - 40, 18.25Azurity Pharmaceu…ActiveVideo Networks, LLC - 40, 17.35Activevideo Netwo…Advanced Architectural Products, LLC - 40, 11.72Advanced Architec…ARK Therapeutic Services, Inc. - 40, 1ARK Therapeutic S…
ARK vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ARK's grants concentrate

ARK Therapeutic Services, Inc. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2023 (18 grants) versus a trough of 1 in 2024. By volume, ARK sits between Alios Biopharma, Inc. and Advanced Architectural Products, LLC.

ARK's three-year grant acceleration

ARK Therapeutic Services, Inc. shows 23 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ARK's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ARK holds 40 patents at rank #7,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ARK

By rank, the assignees closest to #7,974 in granted patent volume.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ARK, neither rank-band nor same-CPC leaders (those blocks stay above).

ARK's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 10th percentile higher than 10% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201920202021202220232024 1
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
ARK Therapeutic Services, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 4 10.0%
2020 3 7.5%
2021 10 25.0%
2022 4 10.0%
2023 18 45.0%
2024 1 2.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

ARK Therapeutic Services, Inc.'s patent record in context - here's where to go next.

  • Ranked #7,977 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ARK Therapeutic Services, Inc. against Alios Biopharma, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 22.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.